APA (7th ed.) Citation

P, E., A, M., A, P., EK, L., A, D., I, S., . . . P, L. (2024). Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera. Vaccines, 12(8), . https://doi.org/10.3390/vaccines12080914

Chicago Style (17th ed.) Citation

P, Eliadis, et al. "Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera." Vaccines 12, no. 8 (2024). https://doi.org/10.3390/vaccines12080914.

MLA (9th ed.) Citation

P, Eliadis, et al. "Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera." Vaccines, vol. 12, no. 8, 2024, https://doi.org/10.3390/vaccines12080914.